cas2381089-83-2 Retatrutide

Skelbimo nr. 296151, įdėtas 2025-03-25 · Perskaitė:

Retatrutide (RETA; LY3437943) is a novel triple agonist of the GIP, GLP-1 and glucagon receptors under investigation for obesity treatment.

Kontaktai